TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Trial Comparing the Pharmacokinetics of Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B
Brief Summary: This trial is conducted in Europe and the United States of America. The aim of this trial is to compare the pharmacokinetics (the exposure of the trial drug in the body) of nonacog beta pegol (N9-GP) and ALPROLIX® in patients with haemophilia B.


Options:
A: Arm Label: Recombinant Factor VIII prophylaxis treatment; Type: EXPERIMENTAL; Interventions: Biological: Recombinant Factor VIII (Kogenate FS, BAY14-2222) | Arm Label: Recombinant Factor VIII on-demand treatment; Type: EXPERIMENTAL; Interventions: Biological: Recombinant Factor VIII (Kogenate FS, BAY14-2222) | Intervention Type: BIOLOGICAL; Name: Recombinant Factor VIII (Kogenate FS, BAY14-2222); Assigned to Arm(s): Recombinant Factor VIII prophylaxis treatment | Intervention Type: BIOLOGICAL; Name: Recombinant Factor VIII (Kogenate FS, BAY14-2222); Assigned to Arm(s): Recombinant Factor VIII on-demand treatment
B: Arm Label: N9-GP; Type: EXPERIMENTAL; Interventions: Drug: N9-GP | Arm Label: ALPROLIX®; Type: ACTIVE_COMPARATOR; Interventions: Drug: ALPROLIX® | Intervention Type: DRUG; Name: N9-GP; Assigned to Arm(s): N9-GP | Intervention Type: DRUG; Name: ALPROLIX®; Assigned to Arm(s): ALPROLIX®
C: Arm Label: Concizumab; Type: EXPERIMENTAL; Interventions: Drug: Concizumab, Drug: Turoctocog alfa | Intervention Type: DRUG; Name: Concizumab; Assigned to Arm(s): Concizumab | Intervention Type: DRUG; Name: Turoctocog alfa; Assigned to Arm(s): Concizumab
D: Arm Label: BAY94-9027 / Adynovi; Type: EXPERIMENTAL; Interventions: Biological: Damoctocog-alfa-pegol (BAY94-9027, Jivi), Biological: Rurioctocog alfa pegol (Adynovi) | Arm Label: Adynovi / BAY94-9027; Type: EXPERIMENTAL; Interventions: Biological: Damoctocog-alfa-pegol (BAY94-9027, Jivi), Biological: Rurioctocog alfa pegol (Adynovi) | Intervention Type: BIOLOGICAL; Name: Damoctocog-alfa-pegol (BAY94-9027, Jivi); Assigned to Arm(s): Adynovi / BAY94-9027, BAY94-9027 / Adynovi | Intervention Type: BIOLOGICAL; Name: Rurioctocog alfa pegol (Adynovi); Assigned to Arm(s): Adynovi / BAY94-9027, BAY94-9027 / Adynovi

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Physical Activity in Children at Risk of Post-thrombotic Sequelae: A Pilot Randomized Controlled Trial
Brief Summary: 'The PACT trial' is randomized pilot trial to demonstrate the feasibility and potential effectiveness of a personal "fitness tracker" to improve adherence to an activity regimen following an initial acute DVT in children.


Options:
A: Arm Label: REVITIVE IX: actual device; Type: ACTIVE_COMPARATOR; Interventions: Device: REVITIVE IX | Arm Label: REVITIVE IX: sham device; Type: SHAM_COMPARATOR; Interventions: Device: REVITIVE IX | Intervention Type: DEVICE; Name: REVITIVE IX; Assigned to Arm(s): REVITIVE IX: actual device, REVITIVE IX: sham device
B: Arm Label: İnspiratory muscle training group; Type: EXPERIMENTAL; Interventions: Other: exercise therapy | Arm Label: Calf muscle training group; Type: EXPERIMENTAL; Interventions: Other: exercise therapy | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: exercise therapy; Assigned to Arm(s): Calf muscle training group, İnspiratory muscle training group
C: Arm Label: Crenobalneotherapy; Type: EXPERIMENTAL; Interventions: Behavioral: Crenobalneotherapy | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Crenobalneotherapy; Assigned to Arm(s): Crenobalneotherapy
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Device: Fitbit, Behavioral: 30-minute education session | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 30-minute education session | Intervention Type: DEVICE; Name: Fitbit; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: 30-minute education session; Assigned to Arm(s): Control, Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Latinos CARES (Colorectal Cancer Awareness, Research, Education and Screening) Project
Brief Summary: The purpose of this study is to conduct 4 focus groups and recruit for 12 participants per focus group to explore community members' views about colorectal cancer screening (CRCS) processes and perceived benefits and impediments, what information they believe should be communicated, communication preferences (style, tone) and perceptions of screenings.


Options:
A: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Intervention | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Intervention; Assigned to Arm(s): 2
B: Arm Label: PREPARE intervention; Type: EXPERIMENTAL; Interventions: Behavioral: PREPARE Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: PREPARE Intervention; Assigned to Arm(s): PREPARE intervention
C: Arm Label: LATINOS CARES Toolkit; Type: ACTIVE_COMPARATOR; Interventions: Other: Immunochemical Fecal Occult Blood Test (I-FOBT) Kit, Behavioral: LATINOS CARES Toolkit | Arm Label: Standard Intervention (SI); Type: ACTIVE_COMPARATOR; Interventions: Other: Immunochemical Fecal Occult Blood Test (I-FOBT) Kit, Behavioral: Standard Intervention | Intervention Type: OTHER; Name: Immunochemical Fecal Occult Blood Test (I-FOBT) Kit; Assigned to Arm(s): LATINOS CARES Toolkit, Standard Intervention (SI) | Intervention Type: BEHAVIORAL; Name: LATINOS CARES Toolkit; Assigned to Arm(s): LATINOS CARES Toolkit | Intervention Type: BEHAVIORAL; Name: Standard Intervention; Assigned to Arm(s): Standard Intervention (SI)
D: Arm Label: Calorie-counting; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Calorie-counting | Arm Label: MyPlate; Type: EXPERIMENTAL; Interventions: Behavioral: MyPlate | Intervention Type: BEHAVIORAL; Name: Calorie-counting; Assigned to Arm(s): Calorie-counting | Intervention Type: BEHAVIORAL; Name: MyPlate; Assigned to Arm(s): MyPlate

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Impact of Pharmaceutical Medication Review, Medication Interview Before Discharge and Follow-up: A Randomized Controlled Trial
Brief Summary: Background

It is well known that the transfer of a patient from hospital to the general practitioner is related with mistakes in the medication of the patient. A report from 2006 measure the number of drug related admissions in Denmark to be 69.000 to 162.000 per year. To reduce these mistakes, more and better communication between the health professionals are suggested. Furthermore medication reviews made by pharmacist seems to reduce the number of drug related readmissions and other drug related issues, which can lead to an economic cost reduction.

Objective

The aim of this study is to investigate the impact of medication review and better communication between the health professionals after discharge of a patient from hospital to the general practitioner. The effect is measured as reducing the number of readmissions and number of visits at the emergency department 30 days and six month after inclusion of the patient.

Method

This study was estimated to include 1500 participants. The patients were randomized to one of three groups; usual care, basic intervention or extended intervention. The usual care received the normal care following the Danish standard procedure. The basic intervention had a medication review by a clinical pharmacist during admission.

The extended interventions group was similar to the basic intervention group plus follow-up with the patient, the general practitioner and if relevant the nursing home and pharmacy one week and six month after discharge by interview with the clinical pharmacist.


Options:
A: Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: basic intervention; Type: SHAM_COMPARATOR; Interventions: Other: basic intervention | Arm Label: extended intervention; Type: SHAM_COMPARATOR; Interventions: Other: extended intervention | Intervention Type: OTHER; Name: basic intervention; Assigned to Arm(s): basic intervention | Intervention Type: OTHER; Name: extended intervention; Assigned to Arm(s): extended intervention
B: Arm Label: MI + IVR; Type: EXPERIMENTAL; Interventions: Behavioral: MI + IVR | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: MI + IVR; Assigned to Arm(s): MI + IVR
C: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Pharmacist-delivered multifaceted intervention | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Pharmacist-delivered multifaceted intervention; Assigned to Arm(s): Intervention group
D: Arm Label: Re-engineered hospital discharge; Type: EXPERIMENTAL; Interventions: Behavioral: Re-Engineered Hospital Discharge | Arm Label: Standard hospital discharge; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Re-Engineered Hospital Discharge; Assigned to Arm(s): Re-engineered hospital discharge

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Supporting Healthful Lifestyles During Pregnancy: A Health Coach Intervention Pilot Study
Brief Summary: In this mixed methods study, the investigators assessed the feasibility and acceptability of a remote health coach intervention to promote healthful lifestyle behaviors among overweight pregnant women. At one northeastern US clinic, the investigators enrolled 30 overweight (pre-pregnancy BMI≥25 kg/m2) pregnant women at a median gestation of 12.5 weeks (IQR: 11-15) into a one arm intervention trial. The investigators connected participants with a health coach to provide behavioral support to help participants adopt or maintain healthy lifestyle goals during pregnancy. Health coaches contacted participants by phone every 2-3 weeks to monitor goals, and sent emails and text messages to check-in between calls. To assess the intervention, participants completed baseline (N=30) and follow-up surveys at the end of the intervention (N=26), as well as follow-up phone interviews (N=18).


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Community Health Workers; Type: EXPERIMENTAL; Interventions: Behavioral: community health workers | Intervention Type: BEHAVIORAL; Name: community health workers; Assigned to Arm(s): Community Health Workers
B: Arm Label: Interactive computer-assisted screening; Type: EXPERIMENTAL; Interventions: Behavioral: Interactive computer-assisted screening (iCAS) | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Interactive computer-assisted screening (iCAS); Assigned to Arm(s): Interactive computer-assisted screening
C: Arm Label: Health Coach Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Health Coach Intervention | Intervention Type: BEHAVIORAL; Name: Health Coach Intervention; Assigned to Arm(s): Health Coach Intervention
D: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Study Intervention for Retention (APFU); Type: EXPERIMENTAL; Interventions: Behavioral: Study Intervention for Retention (APFU) | Intervention Type: BEHAVIORAL; Name: Study Intervention for Retention (APFU); Assigned to Arm(s): Study Intervention for Retention (APFU)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Elastic Abdominal Binder on Pain and Functional Recovery After Cesarean Delivery: a Randomized Controlled Trial
Brief Summary: Cesarean delivery is a common obstetrical procedure and is associated with increased maternal morbidity and mortality. Pain and limited mobilization are major contributing factors that result in delayed functional recovery and complications. Elastic abdominal binder, a wide elastic belt that is wore around the patient's abdomen to support surgical incision after surgery, has been employed by clinicians for pain relief, wound complications prevention, improved pulmonary function, and stabilization. Benefits of the abdominal binder use have not been properly examined.

The aim of this study is to examine the effect of postcesarean elastic abdominal binder use on recovery by comparing pain scores and mobility function (through the 6-minute walk test \[6MWT\]) in postcesarean mothers who use versus do not use the elastic abdominal binder to support incisional site.


Options:
A: Arm Label: Narcotic counseling script; Type: EXPERIMENTAL; Interventions: Behavioral: Narcotic counseling script | Arm Label: Post-partum depression counseling script; Type: SHAM_COMPARATOR; Interventions: Behavioral: Post-partum depression counseling script | Intervention Type: BEHAVIORAL; Name: Narcotic counseling script; Assigned to Arm(s): Narcotic counseling script | Intervention Type: BEHAVIORAL; Name: Post-partum depression counseling script; Assigned to Arm(s): Post-partum depression counseling script
B: Arm Label: Binder; Type: EXPERIMENTAL; Interventions: Device: Elastic abdominal binder | Arm Label: No binder; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Elastic abdominal binder; Assigned to Arm(s): Binder
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Device: Procare abdominal binder | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard of Care | Intervention Type: DEVICE; Name: Procare abdominal binder; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Standard of Care; Assigned to Arm(s): Control
D: Arm Label: Verum acupuncture; Type: EXPERIMENTAL; Interventions: Drug: Standard therapy, Device: Verum acupuncture | Arm Label: Placebo acupuncture; Type: PLACEBO_COMPARATOR; Interventions: Drug: Standard therapy, Other: Placebo acupuncture | Arm Label: Standard therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard therapy | Intervention Type: DRUG; Name: Standard therapy; Assigned to Arm(s): Placebo acupuncture, Standard therapy, Verum acupuncture | Intervention Type: DEVICE; Name: Verum acupuncture; Assigned to Arm(s): Verum acupuncture | Intervention Type: OTHER; Name: Placebo acupuncture; Assigned to Arm(s): Placebo acupuncture

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Community-based Caring Contact on Post-discharge Young Adults With Self-harm - a Multi-center Randomized Controlled Trial
Brief Summary: The study will determine whether community-based caring contact via a mobile app connection with or without volunteer support in addition to treatment as usual (psychiatric and psychosocial treatments) has an effect on suicidal ideation and treatment compliance among post-discharge self-harm young adults.


Options:
A: Arm Label: Standard DBT + PTSD Protocol; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical Behavior Therapy, Behavioral: PTSD Protocol | Arm Label: Standard DBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Dialectical Behavior Therapy | Intervention Type: BEHAVIORAL; Name: Dialectical Behavior Therapy; Assigned to Arm(s): Standard DBT, Standard DBT + PTSD Protocol | Intervention Type: BEHAVIORAL; Name: PTSD Protocol; Assigned to Arm(s): Standard DBT + PTSD Protocol
B: Arm Label: Study participants; Type: EXPERIMENTAL; Interventions: Other: EMA | Intervention Type: OTHER; Name: EMA; Assigned to Arm(s): Study participants
C: Arm Label: TAU w/ mobile app + volunteer support; Type: EXPERIMENTAL; Interventions: Behavioral: Volunteer support, Other: Mobile app | Arm Label: TAU w/ mobile app engagement; Type: EXPERIMENTAL; Interventions: Other: Mobile app | Arm Label: Treatment as Usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Volunteer support; Assigned to Arm(s): TAU w/ mobile app + volunteer support | Intervention Type: OTHER; Name: Mobile app; Assigned to Arm(s): TAU w/ mobile app + volunteer support, TAU w/ mobile app engagement
D: Arm Label: NMDA receptor antagonist; Type: ACTIVE_COMPARATOR; Interventions: Drug: NMDA receptor antagonist (active drug) | Arm Label: Placebo tablet; Type: PLACEBO_COMPARATOR; Interventions: Other: Lactose packed capsule (inert/inactive arm) | Intervention Type: DRUG; Name: NMDA receptor antagonist (active drug); Assigned to Arm(s): NMDA receptor antagonist | Intervention Type: OTHER; Name: Lactose packed capsule (inert/inactive arm); Assigned to Arm(s): Placebo tablet

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Community-based Caring Contact on Post-discharge Young Adults With Self-harm - a Multi-center Randomized Controlled Trial
Brief Summary: The study will determine whether community-based caring contact via a mobile app connection with or without volunteer support in addition to treatment as usual (psychiatric and psychosocial treatments) has an effect on suicidal ideation and treatment compliance among post-discharge self-harm young adults.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Smartphone Assisted PST; Type: EXPERIMENTAL; Interventions: Other: Smartphone Assisted PST | Intervention Type: OTHER; Name: Smartphone Assisted PST; Assigned to Arm(s): Smartphone Assisted PST
B: Arm Label: Peer Mentorship intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Peer mentorship | Arm Label: Enhanced Usual Care (EUC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Usual Care | Intervention Type: BEHAVIORAL; Name: Peer mentorship; Assigned to Arm(s): Peer Mentorship intervention | Intervention Type: BEHAVIORAL; Name: Enhanced Usual Care; Assigned to Arm(s): Enhanced Usual Care (EUC)
C: Arm Label: CARMS therapy + TAU; Type: EXPERIMENTAL; Interventions: Other: Cognitive AppRoaches to coMbatting Suicidality (CARMS) | Arm Label: TAU; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Cognitive AppRoaches to coMbatting Suicidality (CARMS); Assigned to Arm(s): CARMS therapy + TAU
D: Arm Label: TAU w/ mobile app + volunteer support; Type: EXPERIMENTAL; Interventions: Behavioral: Volunteer support, Other: Mobile app | Arm Label: TAU w/ mobile app engagement; Type: EXPERIMENTAL; Interventions: Other: Mobile app | Arm Label: Treatment as Usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Volunteer support; Assigned to Arm(s): TAU w/ mobile app + volunteer support | Intervention Type: OTHER; Name: Mobile app; Assigned to Arm(s): TAU w/ mobile app + volunteer support, TAU w/ mobile app engagement

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Ramucirumab Plus Irinotecan / Leucovorin / 5-FU Versus Ramucirumab Plus Paclitaxel in Patients with Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed One Prior Line of Palliative Chemotherapy - the Phase II/III RAMIRIS Study
Brief Summary: This clinical trial will evaluate whether it is beneficial in terms of prolongation of survival to combine FOLFIRI (standard treatment) with ramucirumab compared to the standard treatment of ramucirumab plus paclitaxel in patients with advanced gastric cancer after failure of one prior line of palliative chemotherapy. This trial aims to investigate the efficacy and safety of ramucirumab plus FOLFIRI (investigational arm A) compared to paclitaxel plus ramucirumab (control arm B).


Options:
A: Arm Label: FOLFIRI plus Ramucirumab; Type: EXPERIMENTAL; Interventions: Drug: FOLFIRI, Drug: Ramucirumab | Arm Label: Paclitaxel plus Ramucirumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ramucirumab, Drug: Paclitaxel | Intervention Type: DRUG; Name: FOLFIRI; Assigned to Arm(s): FOLFIRI plus Ramucirumab | Intervention Type: DRUG; Name: Ramucirumab; Assigned to Arm(s): FOLFIRI plus Ramucirumab, Paclitaxel plus Ramucirumab | Intervention Type: DRUG; Name: Paclitaxel; Assigned to Arm(s): Paclitaxel plus Ramucirumab
B: Arm Label: ramucirumab; Type: EXPERIMENTAL; Interventions: Biological: ramucirumab, Other: Best Supportive Care (BSC) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Other: Best Supportive Care (BSC) | Intervention Type: BIOLOGICAL; Name: ramucirumab; Assigned to Arm(s): ramucirumab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: OTHER; Name: Best Supportive Care (BSC); Assigned to Arm(s): Placebo, ramucirumab
C: Arm Label: Olaparib+ paclitaxel; Type: EXPERIMENTAL; Interventions: Drug: Olaparib, Drug: Paclitaxel | Arm Label: Placebo+paclitaxel; Type: PLACEBO_COMPARATOR; Interventions: Drug: Paclitaxel, Drug: Placebo | Intervention Type: DRUG; Name: Olaparib; Assigned to Arm(s): Olaparib+ paclitaxel | Intervention Type: DRUG; Name: Paclitaxel; Assigned to Arm(s): Olaparib+ paclitaxel, Placebo+paclitaxel | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo+paclitaxel
D: Arm Label: paclitaxel; Type: EXPERIMENTAL; Interventions: Drug: Paclitaxel | Arm Label: irinotecan; Type: EXPERIMENTAL; Interventions: Drug: Irinotecan | Intervention Type: DRUG; Name: Paclitaxel; Assigned to Arm(s): paclitaxel | Intervention Type: DRUG; Name: Irinotecan; Assigned to Arm(s): irinotecan

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: SMART Africa: Addressing African Youth Mental Health by Scaling Family and Community-Level EBPs
Brief Summary: The objective of this research study is to examine the implementation of and outcomes associated with an evidence-based practice (EBP), specifically Multiple Family Group (MFG) targeting youth disruptive behavior challenges and success, through a scale up intervention study in Uganda, and two pilot studies that will be conducted in Kenya and Ghana.


Options:
A: Arm Label: TSM Arm; Type: EXPERIMENTAL; Interventions: Other: Tarang Adolescence Education programme, Other: SEHER Intervention | Arm Label: SM Arm; Type: EXPERIMENTAL; Interventions: Other: Tarang Adolescence Education programme, Other: SEHER Intervention | Arm Label: Comparison Arm; Type: OTHER; Interventions: Other: Tarang Adolescence Education programme | Intervention Type: OTHER; Name: Tarang Adolescence Education programme; Assigned to Arm(s): Comparison Arm, SM Arm, TSM Arm | Intervention Type: OTHER; Name: SEHER Intervention; Assigned to Arm(s): SM Arm, TSM Arm
B: Arm Label: MFG-delivered by trained family peers; Type: EXPERIMENTAL; Interventions: Behavioral: MFG | Arm Label: MFG-delivered by CHWs; Type: EXPERIMENTAL; Interventions: Behavioral: MFG | Arm Label: Bolstered care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: MFG; Assigned to Arm(s): MFG-delivered by CHWs, MFG-delivered by trained family peers
C: Arm Label: Accountable Condition- 8 clinics; Type: EXPERIMENTAL; Interventions: Behavioral: Accountable Condition | Arm Label: Control Condition- 8 clinics; Type: EXPERIMENTAL; Interventions: Behavioral: Control Condition | Intervention Type: BEHAVIORAL; Name: Accountable Condition; Assigned to Arm(s): Accountable Condition- 8 clinics | Intervention Type: BEHAVIORAL; Name: Control Condition; Assigned to Arm(s): Control Condition- 8 clinics
D: Arm Label: Waitlist-Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Common Elements Treatment Approach; Type: EXPERIMENTAL; Interventions: Behavioral: Common Elements Treatment Approach | Intervention Type: BEHAVIORAL; Name: Common Elements Treatment Approach; Assigned to Arm(s): Common Elements Treatment Approach

Answer: B